ALK
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Denmark · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Bøge Allé 6-8, Korsholm, North Denmark, ...Phone Number
+45 45747576Website
www.alk.netRevenue
$955.8 MillionStock Symbol
ALK-BIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About ALK
ALK-Abelló is a global pharmaceutical company specializing in allergy immunotherapy treatments and diagnostics. Based in Denmark, the company develops, manufactures, and markets allergy vaccines and diagnostic products for the prevention and treatment of allergies. ALK focuses on sublingual and subcutaneous immunotherapy solutions that address respiratory allergies, including pollen, dust mites, and other allergens. The company is dedicated to improving the lives of people with allergies through innovative treatment approaches, working closely with healthcare professionals to provide evidence-based allergy care solutions worldwide.Explore more
ALK Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ALK your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ALK, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ALK had a recent Job posting/layoffs
Product Launch: Get notified when ALK launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once ALK has new funding data
Earning: See what the market has to say on ALK recently announced quarterly report
Check if ALK has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ALK
Check out if ALK is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined ALK as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
ALK is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ALK is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ALK.
ALK Tech Stack
A closer look at the technologies used by ALK
See more technologies
Most Recent Scoops
Hiring Plans
ALK has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: SAP.
Hiring Plans
Open Position
Open Position
Open Position
Open Position
ALK News & Media
Invitation to the presentation of ALK’s first six months (Q2) 2026 results on Thursday, 20 August 2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first six months of 2026 in the morning on Thursday, 20 August 2026.Market launch of the nasal adrenaline spray, neffy®, for treatment of adults and children with severe allergies in Canada
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced the market launch of neffy® 2 mg in Canada following the approval by Health Canada in April 2026. The launch of this first ever nasal adrenaline spray for emergency treatment of anaphylaxis represents a significant milestone for adults and children (≥30 kg) experiencing potentially life-threatening allergic reactions due to insect stings or bites, foods, medicines and other allergens, as well as anaphylaxis where the cause isAlaska Air Group, Inc. (ALK) Q2 2026 Earnings Call Transcript
Alaska Air Group, Inc. (ALK) Q2 2026 Earnings Call July 22, 2026 11:30 AM EDTCompany ParticipantsRyan St.Former R&D chief at ALK joins Leo Foundation's board of directors - MedWatch
In addition to her three years as head of research at ALK, Henriette Mersebach has also previously held a number of leadership positions at Novo Nordisk.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ALK
Sign Up For FreeTo access detailed company insights
ALK-Abelló is a global pharmaceutical company specializing in allergy immunotherapy treatments and diagnostics. Based in Denmark, the company develops, manufactures, and markets allergy vaccines and diagnostic products for the prevention and treatment of allergies. ALK focuses on sublingual and subcutaneous immunotherapy solutions that address resp... Read More
